BALY vs WOOF
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
BALY exhibits severe financial distress with a Piotroski F-Score of just 2/9, indicating weak fundamental health. The company is unprofitable with a negative ROE of -115.63%, a deeply negative forward P/E of -8.25, and a profit margin of -17.41%, signaling ongoing earnings deterioration. Despite a low Price/Sales ratio of 0.33 suggesting possible value, extreme leverage (Debt/Equity: 10.85) and poor earnings predictability—evidenced by an average earnings surprise of -149.99% over the last four quarters—undermine any valuation appeal. Technical trend and insider sentiment are neutral to bearish, reinforcing a high-risk profile.
WOOF presents a high-risk profile characterized by a stable but mediocre Piotroski F-Score of 4/9 and a current price ($2.99) that significantly exceeds both its Graham Number ($1.67) and Intrinsic Value ($0.21). The company is struggling with negative revenue growth (-2.40%) and razor-thin profit margins (0.15%), indicating a lack of pricing power or rising operational costs. Financial health is precarious, evidenced by a high Debt/Equity ratio of 2.48 and a critically low Quick Ratio of 0.27. While analysts maintain a 'Hold' rating with a target of $3.52, the combination of bearish insider sentiment and a 0/100 technical trend suggests strong downward pressure.
Compare Another Pair
Related Comparisons
BALY vs WOOF: Head-to-Head Comparison
This page compares Bally's Corporation (BALY) and Petco Health and Wellness Company, Inc. (WOOF) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.